Royalty Pharma plc
Price
FilingsNewest: 10-Q, Quarterly reportAug 5 →InsidersNo open-market buys. 5 insiders sold $71.5M, all 61 sales on a 10b5-1 plan.→PeersClosest companies: LGND, VRTX, CYTK→
From the filings
Figures
- Revenue
- $2.54Blast 12 months
- Net income
- $815.0Mlast 12 months
- Operating cash flow
- $2.61Blast 12 months
- Cash and equivalents
- $812.0Mat the last balance sheet
- Total debt
- $8.96Bat the last balance sheet